CytoDyn Inc. CYDY
- leronlimab — Colorectal Cancer Phase 2
- leronlimab — Triple-Negative Breast Cancer
- leronlimab — Alzheimer's Disease Phase 2
CCR5 (1 companies · 3 programs)
Companies with an active program directed at CCR5.
Companies with an active program directed at CCR5.